Getting back to HIV.....The below are a couple of press releases in march by Gilead regarding HIV. Stories are not overly exciting, until you notice that the 'principal investigator" is Steven Deeks, Professor of Medicine at the University of California, San Francisco (UCSF)
... So, Steven Deeks is a BIOTRON SCIENTIFIC ADVISORY BOARD MEMBER and a PRINCIPLE INVESTIGATOR FOR GILEAD!
Good that he is on the Biotron team whilst they pursue commercialisation!
Shttps://www.gilead.com/news-and-press/press-room/press-releases/2020/3/treatment-with-gileads-vesatolimod-is-evaluated-for-safety-and-virologic-and-immunologic-response-versus-placebo-in-phase-1b-hiv-functional-cure-stud
http://www.pmlive.com/pharma_news/gilead_drug_reduces_hiv_viral_reservoir,_says_researcher_1328920
FYI - Robert L. Murpy, MD (Chair), Executive Director, Institute for Global Health at Northwestern University Feinberg School of Medicine, Chicago, IL, USA. is lso running point on all Covid-19 info in Chicago, on the news daily with updates, but no mention of BIT.
Getting back to HIV.....The below are a couple of press releases...
-
- There are more pages in this discussion • 7,295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |